“…Isocoumarins, also known as 1 H -2-benzopyrans or 3,4-benzopyrones, hold an important position due to their broad pharmacological applications, which include activities of antimicrobial, antifungal, anticancer, anti-HIV, anti-inflammatory, and so on. These facts prompted the synthetic community to establish efficient methods for the construction of isocoumarin scaffolds. , The past two decades witnessed a considerable advancement in transition-metal-catalyzed direct annulation of benzoic acids with unsaturated coupling partners through the activation of their ortho-C–H bond. , This protocol offers rapid access to the isocoumarins from readily available starting materials in a step-economical manner, and is practically beneficial as compared to the conventional acid- or electrophile-mediated cyclization of ortho-alkynylated benzoic acid derivatives (Scheme a,b). Coupling reactions with internal alkynes , have been extensively studied since our group reported the first direct annulation of benzoic acids adopting a Cp*Rh catalyst in 2007. , In addition, terminal alkenes and carbene precursors have also functioned as the coupling partners for the annulation of benzoic acid derivatives. , As a consequence, it is possible to design various 3-mono- and 3,4-disubstituted isocoumarins; however, the basic unit, i.e.…”